0.63
+4.52%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Safeguard Scientifics
From its filings with the US Securities and Exchange Commission
Safeguard Scientifics is based in Radnor, Pennsylvania and is incorporated in Pennsylvania. Its shares trade on OTC under the ticker SFES. The SEC classifies its business as investors, nec. In the fiscal year to 31 December 2009, it reported revenue of $34.8m.
Historically, Safeguard has provided capital and relevant expertise to fuel the growth of technology-driven businesses. In many, but not all cases, we are actively involved influencing development through board representation and management support in addition to the influence we exert through our equity ownership. We also continue to hold relatively small equity interests in other enterprises where we do not exert significant influence and do not participate in management activities. In some cases, those ownership interests relate to residual interests from prior larger interests or from companies that acquired companies in which we had ownership interests.
In January 2018, Safeguard ceased deploying capital into new opportunities in order to focus on supporting the existing ownership interests and maximizing monetization opportunities to enable returning value to shareholders. We have considered and taken action on various initiatives including the sale of individual ownership interests, the sale of certain or all ownership interests in secondary market transactions as well as other opportunities to maximize shareholder value. In December 2019, we declared and paid a $1.00 per share special dividend. In 2021, we repurchased 4.5 million shares through a combination of open market purchases and a tender offer for an aggregate of $40.7 million resulting in an average price of $8.95 per share. In 2022, we repurchased 711,481 shares for $2.9 million at an average price of $4.13 per share through subsequent open market repurchase plans.
Quoted from its 10-K, filed 26 Mar 2024. Read the filing on SEC.gov ↗
Company facts
- Sector
- Financials
- Industry
- Capital Markets
- Listed since
- 17 Mar 1980
- Website
- safeguard.com ↗
- Head office
- 150 NORTH RADNOR-CHESTER ROAD, RADNOR, PA, 19087
- Incorporated in
- PA
- Classification
- Investors, NEC
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Joseph MankoIndependent Chairman of the Board$183,907
- Mr. Mark DowChief Executive Officer, Chief Financial Officer, Company Secretary
- Mr. Ross DemontIndependent Director$132,863
- Mr. Russell GlassIndependent Director$132,863
- Ms. Beth MichelsonIndependent Director$128,004
- Ms. Maureen MorrisonIndependent Director$34,507
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 49
- Environment
- 55
- Social
- 47
- Governance
- 45
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Safeguard Scientifics Inc holds interests in 8 non-consolidated companies.
- The company provides strategic direction to technology-driven businesses.
- Safeguard Scientifics offers management support through board participation.
Weaknesses
- Safeguard Scientifics operates in the Financials sector with limited diversification.
- The company has no listed subsidiaries or consolidated entities.
- Wayne, Pennsylvania is not a major financial hub.
Opportunities
- Expanding into the Information Technology sector for growth opportunities.
- Increasing capital allocation to technology-driven businesses.
- Partnering with more companies in the Capital Markets industry.
Threats
- Competition from other Financial Services firms in the US market.
- Economic downturns affecting capital markets performance.
- Regulatory changes in the Financials sector impacting operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.